//--> //--> //--> //-->
Toggle navigation
Logout
Change account settings
EN
DE
ES
FR
A-Z
Beta
About EconBiz
News
Thesaurus (STW)
Research Skills
Help
EN
DE
ES
FR
My account
Logout
Change account settings
Login
Publications
Events
Your search terms
Search
Retain my current filters
type_genre:"Aufsatz im Buch"
~type_genre:"Conference paper"
Search options
All Fields
Title
Exact title
Subject
Author
Institution
ISBN/ISSN
Published in...
Publisher
Open Access only
Advanced
Search history
My EconBiz
Favorites
Loans
Reservations
Fines
You are here:
Home
Search: subject_exact:"Schmerzmittel"
Narrow search
Delete all filters
| 2 applied filters
Year of publication
From:
To:
Subject
All
Arzneimittel
432
Pharmaceuticals
432
Pharmaceutical industry
116
Pharmaindustrie
116
Deutschland
93
Germany
93
USA
57
United States
57
Gesundheitsversorgung
49
Health care
49
Gesundheitskosten
47
Health care costs
47
Welt
40
World
40
Arzneimittelmarkt
38
Pharmaceutical market
38
India
33
Indien
33
Innovation
30
Pharmacology
27
Pharmakologie
27
Theorie
22
Theory
22
Gesundheitspolitik
21
Health policy
21
Patent
21
Gesundheitswesen
20
Health care system
20
Preisregulierung
20
Price regulation
20
Impfung
19
Vaccination
19
Developing countries
18
Entwicklungsländer
18
Patent law
18
Patentrecht
18
Regulation
18
Regulierung
18
Generic drugs
17
Generika
17
more ...
less ...
Online availability
All
Undetermined
50
Free
9
Type of publication
All
Article
428
Book / Working Paper
4
Type of publication (narrower categories)
All
Aufsatz im Buch
Conference paper
Article in journal
2,789
Aufsatz in Zeitschrift
2,789
Graue Literatur
1,515
Non-commercial literature
1,515
Working Paper
1,321
Arbeitspapier
1,319
Book section
422
Hochschulschrift
155
Thesis
117
Collection of articles of several authors
106
Sammelwerk
106
Amtsdruckschrift
57
Government document
57
Konferenzschrift
50
Case study
38
Fallstudie
38
Aufsatzsammlung
36
Conference proceedings
26
Konferenzbeitrag
23
Collection of articles written by one author
19
Sammlung
19
Bibliografie enthalten
17
Bibliography included
17
Amtliche Publikation
15
Lehrbuch
14
Statistik
14
Textbook
12
Statistics
11
Bibliografie
10
Market information
9
Marktinformation
9
Mehrbändiges Werk
8
Multi-volume publication
8
Rezension
8
Glossar enthalten
6
Glossary included
6
Advisory report
4
Book review
4
more ...
less ...
Language
All
English
306
German
122
French
4
Author
All
Glaeske, Gerd
6
Lichtenberg, Frank R.
6
Berndt, Ernst R.
5
Schulenburg, Johann-Matthias von der
5
Cassel, Dieter
4
Selvaraj, Sakthivel
4
Wille, Eberhard
4
Birg, Laura
3
Farooqui, Habib Hasan
3
Kremer, Michael
3
McFadden, Daniel
3
Pauly, Mark V.
3
Rudholm, Niklas
3
Saggi, Kamal
3
Serra-Sastre, Victoria
3
Tebinka-Olbrich, Anja
3
Towse, Adrian
3
Ulrich, Volker
3
Baehr, Michael
2
Bergman, Mats A.
2
Bohn, Matthias
2
Bond, Eric W.
2
Borges, Ana Pinto
2
Cockburn, Iain
2
Conti, Rena M.
2
Coriat, Benjamin
2
Crémieux, Pierre-Yves
2
Danzon, Patricia M.
2
Danzon, Patricia Munch
2
Ecker, Thomas
2
Ekelund, Mats
2
Finkelstein, Amy
2
Gaudillière, Jean-Paul
2
Goldman, Dana P.
2
Grabowski, Henry G.
2
Grootendorst, Paul V.
2
Hecken, Josef
2
Heiss, Florian
2
Hennrich, Michael
2
Kritchanchai, Duangpun
2
more ...
less ...
Published in...
All
Green and sustainable pharmacy : [1st International Conference on Sustainable Pharmacy]
14
Indian pharmaceutical industry : strategies and challenges in formulations marketing
14
Arzneimittel-Supply-Chain : Marktsituation, aktuelle Herausforderungen und innovative Konzepte
13
Pharmalogistik : Prozesse - Instrumente - Praxisbeispiele
12
Innovation and marketing in the pharmaceutical industry : emerging practices, research, and policies
10
Development of scientific marketing in the twentieth century : research for sales in the pharmaceutical industry
9
Handbuch Market-Access : Marktzulassung ohne Nebenwirkungen
9
The Oxford handbook of the economics of the biopharmaceutical industry
9
Pharmaceutical innovation : incentives, competition, and cost-benefit analysis in international perspective
8
Access to medicines in India
6
Investing in health : the social and economic benefits of health care innovation
6
Effizienz, Qualität und Nachhaltigkeit im Gesundheitswesen : Theorie und Politik öffentlichen Handelns, insbesondere in der Krankenversicherung ; Festschrift zum 65. Geburtstag von Eberhard Wille
5
Pharmaökonomie in Deutschland : gesetzliche Rahmenbedingungen, Vorgaben und Umsetzung in die Praxis
5
Leadership and management in pharmacy practice
4
The economics of medical technology
4
The economics of new health technologies : incentives, organisation and financing
4
Dienstleistungspotenziale und Geschäftsmodelle in der Personalisierten Medizin : Konzepte, Analysen und Potenziale
3
Doping am Arbeitsplatz : Problembewältigung und Leistungssteigerung um jeden Preis?
3
Economic dimensions of personalized and precision medicine
3
Herausforderungen des medizinischen Fortschritts im Krankenhaus- und Arzneimittelbereich : 24. Bad Orber Gespräche über kontroverse Themen im Gesundheitswesen
3
International public goods and transfer of technology under a globalized intellectual property regime
3
Measuring and modeling health care costs
3
Modelling our future : population ageing, health and aged care
3
The Swedish pharmaceuticals market : essays on entry, competition and antibiotic resistance
3
Bittere Arznei : Wirtschaftsethik und Ökonomik der pharmazeutischen Industrie
2
Competition and innovation in the Swedish pharmaceutical market
2
Consumer behavior
2
Engaging the new world : responses to the knowledge economy ; in honour of Peter J. Sheehan
2
Festschrift für Prof. Dr. J.-Matthias Graf von der Schulenburg : aktuelle versicherungs- und gesundheitsökonomische Beiträge
2
Gesundheitsökonomie und Gesundheitspolitik im Spannungsfeld zwischen Wissenschaft und Politikberatung : [Festschrift für Günter Neubauer]
2
Gesundheitsökonomie und Wirtschaftspolitik : Festschrift zum 70. Geburtstag von Prof. Dr. Dr. h.c. Peter Oberender
2
Global pharmaceuticals : ethics, markets, practices
2
Handbook of health economics ; Volume two
2
Intellectual property, public policy and international trade
2
Knowledge accumulation and industry evolution : the case of Pharma-Biotech
2
Krankenhausmanagement : Strategien, Konzepte, Methoden
2
Managing the Future Supply Chain : current concepts and solutions for reliability and robustness
2
Market Access im Gesundheitswesen : Hürden und Zugangswege zur Gesundheitsversorgung
2
Multidisciplinary approaches to organizational governance during health crises
2
New techniques for brand management in the healthcare sector
2
more ...
less ...
Source
All
ECONIS (ZBW)
432
Showing
351
-
400
of
432
Sort
Relevance
Date (newest first)
Date (oldest first)
351
Ökonomische Begründungen für Pharmamarktregulierungen auf verschiedenen Kompetenzebenen : das Beispiel der Arzneimittel-Zulassungshürden in Europa
Cassel, Dieter
;
Müller, Christian
;
Sundmacher, Torsten
- In:
Zentralität und Dezentralität von Regulierung in …
,
(pp. 287-307)
.
2007
Persistent link: https://www.econbiz.de/10003502066
Saved in:
352
Rationality and global governance : mediating the conflict over access to essential medicines through deliberations between TNCs and NGOs
Döbert, Rainer
;
Daele, Wolfgang van den
- In:
Global governance and the role of non-state actors
,
(pp. 157-178)
.
2006
Persistent link: https://www.econbiz.de/10003320209
Saved in:
353
The benefits to society of new drugs : a survey of the econometric evidence
Lichtenberg, Frank R.
- In:
Engaging the new world : responses to the knowledge …
,
(pp. 204-221)
.
2006
Persistent link: https://www.econbiz.de/10003335004
Saved in:
354
Australian pharmaceutical pricing in a global context : trends and issues
Sweeny, Kim
- In:
Engaging the new world : responses to the knowledge …
,
(pp. 280-304)
.
2006
Persistent link: https://www.econbiz.de/10003335019
Saved in:
355
Socially responsible pricing: lessons from pricing of AIDS drugs in developing countries
Vachani, Sushil
;
Smith, N. Craig
- In:
Multinational corporations and global poverty reduction
,
(pp. 400-434)
.
2006
Persistent link: https://www.econbiz.de/10003278795
Saved in:
356
Alternativen zum weltweiten Patentschutz für pharmazeutische Innovationen
Stolpe, Michael
- In:
Die wunderbare Wissensvermehrung : wie Open Innovation …
,
(pp. 121-132)
.
2006
Persistent link: https://www.econbiz.de/10003736177
Saved in:
357
The pharmaceutical nexus
Petryna, Adriana
;
Kleinman, Arthur
- In:
Global pharmaceuticals : ethics, markets, practices
,
(pp. 1-32)
.
2006
Persistent link: https://www.econbiz.de/10003415449
Saved in:
358
Pharmaceutical governance
Biehl, João
- In:
Global pharmaceuticals : ethics, markets, practices
,
(pp. 206-239)
.
2006
Persistent link: https://www.econbiz.de/10003415524
Saved in:
359
The evolution of pharmaceutical innovation
Nightingale, Paul
;
Mahdi, Surya
- In:
Knowledge accumulation and industry evolution : the …
,
(pp. 73-111)
.
2006
Persistent link: https://www.econbiz.de/10003402117
Saved in:
360
The growth of pharmaceutical firms : a comment
Jovanovic, Boyan
- In:
Knowledge accumulation and industry evolution : the …
,
(pp. 266-273)
.
2006
Persistent link: https://www.econbiz.de/10003402174
Saved in:
361
Facilitating compulsory licensing under TRIPS in response to the AIDS crisis in developing countries
Lidgard, Hans Henrik
;
Atik, Jeffery
- In:
Corporate and employment perspectives in a global …
,
(pp. 49-64)
.
2006
Persistent link: https://www.econbiz.de/10003402655
Saved in:
362
Kontinuität und Diskontinuität in der Gesetzgebung zur Arzneimittelversorgung seit 1988
Schulte, Gerhard
- In:
Gesundheitsökonomie und Gesundheitspolitik im …
,
(pp. 527-542)
.
2006
Persistent link: https://www.econbiz.de/10003383868
Saved in:
363
Mit bitteren Pillen gesunde Geschäfte : von mangelnder Differenzierung des Marktes und den Erfolgen von Analogprodukten
Glaeske, Gerd
- In:
Gesundheitsökonomie und Gesundheitspolitik im …
,
(pp. 543-559)
.
2006
Persistent link: https://www.econbiz.de/10003384086
Saved in:
364
Prescription drug insurance and reimbursement
Grootendorst, Paul V.
- In:
The Elgar companion to health economics
,
(pp. 114-125)
.
2006
Persistent link: https://www.econbiz.de/10003389291
Saved in:
365
Statistical methods for cost-effectiveness analysis alongside clinical trials
Briggs, Andrew
- In:
The Elgar companion to health economics
,
(pp. 503-513)
.
2006
Persistent link: https://www.econbiz.de/10003389724
Saved in:
366
Developing a sustainable medicinal-plant chain in India : linking people, markets and values
Kop, Petra van de
;
Alam, Ghayur
;
Steenhuijsen Piters, …
- In:
The agro-food chains and networks for development
,
(pp. 191-202)
.
2006
Persistent link: https://www.econbiz.de/10003355029
Saved in:
367
Choosing the first-line drug for malaria treatment : how can cost-effectiveness analysis inform policy?
Goodman, Catherine
;
Abdulla, Salim
;
Coleman, Paul
; …
- In:
The economics of infectious disease
,
(pp. 23-48)
.
2006
Persistent link: https://www.econbiz.de/10003439564
Saved in:
368
Governing innovative science : challenges facing the commercialization of plant-made pharmaceuticals
Smyth, Stuart
;
Khachatourians, George K.
;
Phillips, …
- In:
International trade and policies for genetically …
,
(pp. 133-146)
.
2006
Persistent link: https://www.econbiz.de/10003326914
Saved in:
369
Codes of business conduct : pharma marketing at a crossroads
Jadeja, Jayraj
;
Shah, Bharat R.
;
Bhardwaj, Preshth
- In:
Perspectives on international corporate responsibility …
,
(pp. 359-374)
.
2005
Persistent link: https://www.econbiz.de/10009385497
Saved in:
370
WTO regime, pharmaceutical industry and prices of medicines in India : an analysis
Kaur, Kuldip
-
2005
Persistent link: https://www.econbiz.de/10003334318
Saved in:
371
Patent protection of pharmaceutical products in the globalising world economy
Kukrus, Ants J.
;
Kartus, Raul
-
2005
Persistent link: https://www.econbiz.de/10003399724
Saved in:
372
Der Markt der Gesundheit - neue Herausforderungen für PR und Werbung
Gottwald, Franzisca
- In:
Theorie und Praxis der Werbung in den Massenmedien
,
(pp. 166-181)
.
2005
Persistent link: https://www.econbiz.de/10003203408
Saved in:
373
Pharmaceutical knowledge-capital accumulation and longevity
Lichtenberg, Frank R.
- In:
Measuring capital in the new economy
,
(pp. 237-269)
.
2005
Persistent link: https://www.econbiz.de/10003080944
Saved in:
374
Theory and implementation of differential pricing for pharmaceuticals
Danzon, Patricia Munch
;
Towse, Adrian
- In:
International public goods and transfer of technology …
,
(pp. 457-492)
.
2005
Persistent link: https://www.econbiz.de/10003414413
Saved in:
375
Increasing R&D incentives for neglected diseases : lessons from the Orphan Drug Act
Grabowski, Henry
- In:
International public goods and transfer of technology …
,
(pp. 425-456)
.
2005
Persistent link: https://www.econbiz.de/10003414416
Saved in:
376
Recognizing public goods in WTO dispute settlement : who participates? Who decides? The case of TRIPS and pharmaceutical patent protection
Shaffer, Gregory C.
- In:
International public goods and transfer of technology …
,
(pp. 884-908)
.
2005
Persistent link: https://www.econbiz.de/10003415336
Saved in:
377
Discovering clinical evidence for evidence-based medicine
Chen, Yunan
;
Chen, Chaomai
- In:
Knowledge management : nurturing culture, innovation …
,
(pp. 247-259)
.
2005
Persistent link: https://www.econbiz.de/10003383887
Saved in:
378
Developing and distributing essential medicines to poor countries: the defend proposal
Ganslandt, Mattias
;
Maskus, Keith E.
;
Wong, Eina Vivian
- In:
Intellectual property and development : lessons from …
,
(pp. 207-223)
.
2005
Persistent link: https://www.econbiz.de/10002605737
Saved in:
379
Preisregulierung, Kosten der Arzneimitteldistribution und leistungsorientierte Apothekervergütung
Adam, Hans
- In:
Wettbewerb und Regulierung im Gesundheitswesen : …
,
(pp. 161-180)
.
2004
Persistent link: https://www.econbiz.de/10002401387
Saved in:
380
Apothekenabgabepreise : Einheitspreise mit regulierten Zuschlägen oder Wettbewerbspreise?
Prinz, Aloys
- In:
Wettbewerb und Regulierung im Gesundheitswesen : …
,
(pp. 181-201)
.
2004
Persistent link: https://www.econbiz.de/10002401407
Saved in:
381
The European pharmaceutical price structure and price levels
Pasternak Jørgensen, Kasper
- In:
Aspects of innovation and innovative industries
,
(pp. 1-85)
.
2003
Persistent link: https://www.econbiz.de/10001822812
Saved in:
382
Why do the Japanese spend so much on drugs?
Ogura, Seiritsu
;
Hagino, Takehiko
- In:
Labor markets and firm benefit policies in Japan and …
,
(pp. 229-265)
.
2003
Persistent link: https://www.econbiz.de/10001828687
Saved in:
383
The long shadow of patent expiration : generic entry and Rx-to-OTC switches
Berndt, Ernst R.
;
Kyle, Margaret K.
;
Ling, Davina C.
- In:
Scanner data and price indexes
,
(pp. 229-267)
.
2003
Persistent link: https://www.econbiz.de/10001832900
Saved in:
384
Analysis of trade in non-timber forest products
Smith Olsen, Carsten
;
Treue, Thorsten
- In:
Recent accomplishments in applied forest economics research
,
(pp. 227-239)
.
2003
Persistent link: https://www.econbiz.de/10001996563
Saved in:
385
Echter medizinischer Fortschritt bei Medikamenten und die Frage der Innovationsbewertung in Deutschland : Sichtweise einer multinational tätigen Firma
Volmer, Timm
-
2003
Persistent link: https://www.econbiz.de/10001889159
Saved in:
386
Das Schweizer Modell des Arzneimittelversandhandles - Modell für den europäischen Binnenmarkt?
Kerckhoff, Thomas
- In:
Europäischer Binnenmarkt und Wettbewerb : …
,
(pp. 180-192)
.
2003
Persistent link: https://www.econbiz.de/10001763142
Saved in:
387
Boomers on drugs : marketing healthcare products to the baby boom generation
Devereux, Anne
- In:
After fifty : how the baby boom will redefine the …
,
(pp. 77-92)
.
2003
Persistent link: https://www.econbiz.de/10003671747
Saved in:
388
Pharmaceutical sector of Bangladesh : trade prospects with Nepal and the impact of TRIPS
Ferhat Anwar, Syed
- In:
Towards greater sub-regionl economic cooperation : …
,
(pp. 217-257)
.
2002
Persistent link: https://www.econbiz.de/10001738126
Saved in:
389
A comparison of alternative models of prescription drug utilization
Grootendorst, Paul V.
- In:
Econometric analysis of health data
,
(pp. 73-86)
.
2002
Persistent link: https://www.econbiz.de/10001773698
Saved in:
390
Steuerungsinstrumente der Arzneimittelausgaben
Wille, Eberhard
- In:
Konfliktfeld Arzneimittelversorgung : [enthält die …
,
(pp. 35-47)
.
2002
Persistent link: https://www.econbiz.de/10001715236
Saved in:
391
A patent policy proposal for global diseases
Lanjouw, Jean Olson
- In:
Annual World Bank Conference on Development Economics …
,
(pp. 189-209)
.
2002
Persistent link: https://www.econbiz.de/10001673856
Saved in:
392
IPR and drugs and the pharmaceutical industry : concerns for developing countries
Raizada, B. K.
;
Sayed, Javed
- In:
Salvaging the WTO's future : Doha and beyond
,
(pp. 274-289)
.
2002
Persistent link: https://www.econbiz.de/10001703150
Saved in:
393
Biodiversity : a heritage under threat, the ruthless persuit of resources and the very essence of life
Barbault, Robert
- In:
Johannesburg 2002, World Summit on Sustainable …
,
(pp. 53-80)
.
2002
Persistent link: https://www.econbiz.de/10001725971
Saved in:
394
The frontiers of genetics and the transformation of medicine and business
Field, Robert
- In:
Investing in health : the social and economic benefits …
,
(pp. 1-22)
.
2001
Persistent link: https://www.econbiz.de/10001640122
Saved in:
395
Outpatient prescription drug prices and insurance coverage : an analysis by therapeutic drug class and user characteristics from the 1996 Medical Expenditure Panel Survey
Miller, G. Edward
;
Moeller, John
- In:
Investing in health : the social and economic benefits …
,
(pp. 23-57)
.
2001
Persistent link: https://www.econbiz.de/10001640125
Saved in:
396
Pharmaceutical spending and health outcomes in the United States
Crémieux, Pierre-Yves
(
contributor
)
- In:
Investing in health : the social and economic benefits …
,
(pp. 59-75)
.
2001
Persistent link: https://www.econbiz.de/10001640128
Saved in:
397
Too many drugs? : The clinical and economic value of incremental innovations
Wertheimer, Albert
;
Levy, Richard
;
O'Connor, Thomas
- In:
Investing in health : the social and economic benefits …
,
(pp. 77-118)
.
2001
Persistent link: https://www.econbiz.de/10001640130
Saved in:
398
Factors affecting health services utilization in the Medicare population : would providing prescription drug coverage to Medicare recipients affect their use of health care resourc...
Cifaldi, Mary
- In:
Investing in health : the social and economic benefits …
,
(pp. 119-141)
.
2001
Persistent link: https://www.econbiz.de/10001640131
Saved in:
399
Estimating the social and economic benefits of pharmaceutical innovation : modeling clinical trial results in HIV-disease
Simpson, Kit
(
contributor
)
- In:
Investing in health : the social and economic benefits …
,
(pp. 175-196)
.
2001
Persistent link: https://www.econbiz.de/10001640134
Saved in:
400
The impact of generic competition on brand name market shares : evidence from micro data
Aronsson, Thomas
;
Bergman, Mats A.
;
Rudholm, Niklas
- In:
The Swedish pharmaceuticals market : essays on entry, …
,
(pp. 1-13)
.
2001
Persistent link: https://www.econbiz.de/10001573284
Saved in:
First
Prev
1
2
3
4
5
6
7
8
9
Next
Last
Results per page
10
25
50
100
250
A service of the
zbw
×
Loading...
//-->